Autoimmune Disease Diagnosis Market worth USD 9.79 billion by 2031 | Autoimmune Disease Diagnosis Industry to grow at a CAGR of 8.6% by 2021 to 2031, Says Growth Plus Reports

Pune, Dec. 02, 2021 (GLOBE NEWSWIRE) -- According to the latest trending report published by growth plus reports Titled “Autoimmune Disease Diagnosis Market – Global Outlook & Forecast 2021-2031” The Global Autoimmune Disease Diagnosis Market is expected to clock US$ ~9.79 billion by 2031 owing to the rising incidence of autoimmune diseases and growing public awareness about autoimmune diseases and their diagnosis.

Growth Engines

• The rising prevalence of autoimmune diseases such as type 1 diabetes, rheumatoid arthritis, lupus, Crohn’s disease, and multiple sclerosis, among others is one of the key factors driving the growth of the autoimmune disease diagnosis market.
• Moreover, the increasing geriatric population, rise in healthcare expenditure, and the growing number of product launches are some of the other factors fueling the autoimmune disease diagnostics market growth.
• Furthermore, the growing awareness about autoimmune diseases and the need for diagnosis are boosting the market growth.

The global autoimmune disease diagnosis market has been analyzed from four perspectives: Product, Type, Test Type, and Region.

Request a Sample Copy of the Research Report: https://growthplusreports.com/request-sample-report/?autoimmune-disease-diagnosis-market

Excerpts from ‘By Type Segmentation’

Based on type, the market has been segmented into localized autoimmune disease diagnostics and systemic autoimmune disease diagnostics. Localized autoimmune disease diagnostics segment is further bifurcated into type 1 diabetes, multiple sclerosis, idiopathic thrombocytopenic purpura, Hashimoto's thyroiditis, and others (such as Addison’s disease, grave’s disease, myasthenia gravis, etc.). Similarly, systemic autoimmune disease diagnostics is categorized into rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus (SLE), and others (scleroderma, sjögren’s syndrome, antiphospholipid antibody syndromes, etc.). Localized autoimmune disease diagnostics dominated the autoimmune disease diagnosis market in terms of revenue in 2020. Factors driving the growth of this segment include the rising incidence of localized autoimmune diseases such as type 1 diabetes, and multiple sclerosis; and growing patient awareness for getting tested for these diseases.

Excerpts from ‘By Region Segmentation’

Regionally, the global autoimmune disease diagnosis market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America dominated the market for autoimmune disease diagnosis holding the largest market share in 2020. The rising incidence of autoimmune diseases and conduct of greater number of tests are fueling the demand for diagnostic products for autoimmune diseases in the region. According to the National Institutes of Health, around 23.5 million Americans i.e., more than 7% of the population suffer from an autoimmune disease. Moreover, factors such as greater awareness regarding the diseases and the available tests; and high healthcare expenditure are anticipated to boost the market growth during the projected period.

Get your customized report right now: https://growthplusreports.com/ask-for-customization/?autoimmune-disease-diagnosis-market

Excerpts from ‘Competitive Landscape’

Some of the prominent players operating in the global autoimmune disease diagnosis market include

• Thermo Fisher Scientific Inc
• Siemens Healthcare Private Limited
• Abbott
• Trinity Biotech Plc
• F. Hoffmann-La Roche Ltd
• Bio-Rad Laboratories, Inc
• Beckman Coulter, Inc
• bioMérieux SA
• Euroimmun Medizinische Labordiagnostika AG (a PerkinElmer company)
•  Inova Diagnostics

Report Scope:

Table of contents:

1. INTRODUCTION
   1. Market Ecosystem
   2. Geographic Scope
   3. Timeline Under Consideration
      1. Historical Years – 2018 & 2019
      2. Base Year – 2020
      3. Forecasted Years – 2021 to 2031
   4. Currency Used in the Report
2. RESEARCH METHODOLOGY
   1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources
      2. Primary Sources
   4. Market Estimation Approach
      1. Bottom Up
      2. Top Down
   5. Market Forecasting Model
   6. Limitations and Assumptions
3. PREMIUM INSIGHTS
   1. Current Market Trend (COVID-19 Perspective)
   2. Key Players & Their Competitive Positioning (2020)
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints/Challenges
   3. Opportunities

And more…

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on 'Strategic Developments' registered by leading players of the market

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• 'Business Profile' of Key Players

Check for a discount now at: https://growthplusreports.com/check-discount/?autoimmune-disease-diagnosis-market

About Us:

Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.